[与代谢功能障碍相关的脂肪性肝病及其与肥胖青少年糖尿病前期的关联]
Catalina Peralta-Cortázar1, Diana Berenice García-Gómez2, Alma Patricia González3
1Instituto Mexicano del Seguro Social, Centro Médico Nacional del Bajío, Unidad Médica de Alta Especialidad, Hospital de Gineco Pediatría No. 48, Servicio de Endocrinología Pediátrica. León, Guanajuato, México.
Revista medica del Instituto Mexicano del Seguro Social
|March 3, 2026
概括
肥胖青少年的代谢功能障碍相关的脂肪性肝病 (MASLD) 与糖尿病前期有关. 超声波诊断的MASLD与糖尿病前期有显著的关联,突出了其临床相关性.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是与肥胖和胰岛素抵抗相关的日益关注的问题.
- 由于潜在的严重健康后果,早期识别MASLD至关重要.
- 脂肪肝指数 (FLI) 和肝超声波越来越多地用于检测MASLD.
研究的目的:
- 调查FLI和超声波检测发现的MASLD与肥胖青少年糖尿病前期之间的关联.
- 评估FLI和超声波在预测MASLD中的诊断效用. 在这个儿科群体中.
主要方法:
- 一项横截面研究包括89名患有肥胖的儿科患者 (10-16岁).
- 收集的数据包括临床和人体测量测量,生化变量,FLI和肝脏超声波.
- 对患者进行了MASLD和糖尿病前期状态的评估.
主要成果:
- 在89名参与者中,30.3%患有前糖尿病,62.9% (FLI) 或69.6% (超声波) 患有MASLD.
- 通过超声波诊断的MASLD与糖尿病前期显著相关 (OR3.39,p=0.04).
- 在患有糖尿病前期的74%肥胖青少年中,FLI呈阳性.
结论:
- 超声波检测到的MASLD与肥胖青少年的糖尿病前期有关.
- 需要进一步的研究来验证FLI作为儿童糖尿病前期早期MASLD检测的非侵入性标志物.
- 在儿童肥胖症中早期发现和管理MASLD至关重要.
相关概念视频
Overview of Lipid Metabolism
7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Inborn Errors of Metabolism
1.1K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28


